Posts about
Statistics and Programming
Veristat Expands Biometrics Capabilities by Acquiring SQN Clinical
Builds on a shared pedigree of data management, statistics and programming excellence across all phases of clinical trials
SOUTHBOROUGH, MA...
Veristat Expands Operations into Taiwan
Veristat Expands Operations into Taiwan to Support Growing Client Demand for Clinical Trial, Biostatistics and Programming Excellence in the...
Veristat Supports Antibe Therapeutics for Pain and Inflammation Study
Upon receiving approval from Health Canada, Antibe Therapeutics selected Veristat to immediately begin work on part one of a Phase 2B...
Veristat Congratulates Alnylam on the FDA Approval of ONPATTRO™
Continues Collaboration to Provide Regulatory Submission Support for Additional Patisiran Submissions
SOUTHBOROUGH, MA – August 20, 2018...
Veristat Congratulates Agios on the FDA Approval of TIBSOVO®
The First Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH1 Mutation
SOUTHBOROUGH, MA –...